Psoriasis Cream Dr. DERM, developed by professional dermatologists, treats the symptoms of psoriasis while moisturizing and restoring the skin's protective barrier. The anti-psoriasis remedy removes scales and dead cells and helps restore skin moisture, preventing the recurrence of psoriasis symptoms. The use of the drug helps to briefly stop the worsening symptoms and treat psoriasis in the short term.
Pre-cleanse the skin with a neutral lotion. Report Dr. DERM to the affected areas one to four times a day or as directed by a healthcare professional. You can also view the patient information included in the product.
Instructions for use of the preparation:
Inflammation of the skin is sensitive to UV rays. Avoid direct sunlight on wounds during therapy. Use sunscreen, wear protective clothing and limit sun exposure while using Dr. DERM and within a week after completion of treatment procedures. The recommended course of therapy is 28 days. Doctors advise that the treatment be repeated after 2-3 months for the purpose of prevention.
|Week 1||The cream removes inflammation, itching, dandruff, deposits.|
|Week 2||The process of regeneration of damaged tissue is started due to the normalization of the cell division cycle.|
|Week 3||Body PH is normalized, skin tone is increased. The skin becomes firm and elastic.|
|Week 4||If you follow a diet, the disease will not get worse.|
Dr. DERM is indicated for the treatment of mild to moderate psoriasis. The drug reduces inflammation, reduces itching and slows down cell production. Types of psoriasis for which the use of a cream is recommended:
Dr. DERM should be applied directly to the affected area when undergoing treatment or when symptoms flare up.
Anti-psoriasis drug Dr. DERM is based on natural hypoallergenic components and does not cause side effects. The use of the drug is not recommended in the following cases:
Care should be taken to use the cream if there is a pronounced allergic reaction to the components of the drug. The drug has passed all stages of clinical trials in laboratory conditions in Poland.